Blog: Research

The MS Society explore 5 myths about cannabis and MS

23 November 2017

Source MS Society:

There’s mounting evidence to show that cannabis could help pain and muscle spasms for people with MS. But with tonnes of information swirling around the internet, it’s hard to be sure what’s true and what’s not.

We dived into the details to bust 5 common myths about cannabis and MS:

1. ‘Cannabis for medicinal use’ means any kind of cannabis

This can be confusing, as the media often refers to both licensed cannabis products and the illegal...

Ozanimod Superior to Avonex in Treating Relapsing MS in Phase 3 Trials, Celgene Reports

23 November 2017

Source Multiple Sclerosis News Today:

Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy, Avonex (interferon β-1a).

These results will be used to support a request for ozanimod’s approval as an MS therapy with the U.S. Food and Drug Administration (FDA), a filing known as a New Drug...

Cannabinoid, Dronabinol, Seen as Long-term Treatment Option for Neuropathic Pain in Phase 3 Study

23 November 2017

Source Multiple Sclerosis News Today:

Multiple sclerosis (MS) patients being treated with dronabinol, a cannabinoid, do not show signs of drug abuse or dependency, leading researchers to conclude it has potential to be a long-term and safe treatment option for neuropathic pain.

The Search for a Miracle Cure - Channel 4, 23rd November at 10pm

23 November 2017

Source Radio Times:

Documentary following leading lawyer Mark Lewis, the man who fought the News of the World in the phone hacking scandal, as he joins a clinical trial that might offer a breakthrough cure for multiple sclerosis. He learned he had the condition at the age of 25 but his high-profile battle with the tabloids has exacerbated his symptoms. Now 50, he travels to Hadassah University Medical Centre in Jerusalem, where the work being done could have a positive impact on...

Targeting Blood-clotting Protein Can Restore Brain’s Potential to Repair Myelin Layer, Study Shows

8 November 2017

Source Multiple Sclerosis News Today:

A blood-clotting protein called fibrinogen prevents myelin production and blocks the neuron remyelination repair process in mice, a study finds.

Cladribine: new oral treatment to be available for people with relapsing MS

8 November 2017

Source MS Society:

A new oral treatment for relapsing MS, called cladribine, will be made available on the NHS in England and Wales within the next three months.

Diagnostic Blood Test May Be Able to Distinguish Between RRMS and PPMS, Researchers Say

8 November 2017

Source Mutiple Sclerosis News Today:

In the future, a blood test may make diagnosing multiple sclerosis (MS) much easier, thanks to newly identified biomarker patterns that distinguish between MS patients and healthy people.

Positive results for clinical trial in progressive MS

31 October 2017

Source MS Society:

Researchers in the US have proclaimed their initial test of ibudilast for MS a success.

MS Society Research Talk 13th November

31 October 2017

Research Talk

Date: Monday 13th November 2017, Time: 10:30 - 13:30 Venue: The Salvation Army Hall Chalfont Close, Lower Earley, RG6 5HZ

Swiss Genomics Firm, Biogen and Microsoft Team Up to Treat Multiple Sclerosis

31 October 2017

Source Labiotech.eu

BC Platforms and Microsoft will be working with Biogen and the Accelerated Cure Project to study the genetics of multiple sclerosis and accelerate research.

Pages

Category

Archive